HomeOPK • NASDAQ
add
OPKO Health Inc
Previous close
$1.74
Day range
$1.73 - $1.80
Year range
$0.86 - $1.84
Market cap
1.19B USD
Avg Volume
3.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 183.60M | 0.93% |
Operating expense | 87.30M | -7.49% |
Net income | 14.00M | 121.06% |
Net profit margin | 7.63 | 120.88% |
Earnings per share | — | — |
EBITDA | -8.94M | 79.25% |
Effective tax rate | 59.89% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 431.90M | 350.45% |
Total assets | 2.20B | 9.37% |
Total liabilities | 834.80M | 34.11% |
Total equity | 1.37B | — |
Shares outstanding | 676.79M | — |
Price to book | 0.86 | — |
Return on assets | -3.71% | — |
Return on capital | -4.34% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 14.00M | 121.06% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK". Wikipedia
Founded
1991
Headquarters
Website
Employees
3,930